Economia

Qianhai Forum on High-Quality Development of Shenzhen-Hong Kong Modern Service…

Maintaining a vibrant momentum for development With institutional innovation at its core, Qianhai is steadily expanding institutional opening-up in terms of rules, regulations, management, and standards. To this end, Qianhai has launched a total of 882 institutional innovation achievements. With the modern service industry as its primary sector, Qianhai is vigorously facilitating the construction of 18 industrial clusters. Statistics released by the Authority of Qianhai Shenzhen-Hong Kong...

International Petroleum Corporation Announces Results of Normal Course Issuer…

International Petroleum Corporation (IPC or the Corporation) (TSX, Nasdaq Stockholm: IPCO) is pleased to announce that IPC repurchased a total of 115,804 IPC common shares (ISIN: CA46016U1084) during the period of December 5 to 6, 2024 under IPC's normal course issuer bid / share repurchase program (NCIB). IPC's NCIB, announced on December 3, 2024, is being implemented in accordance with the Market Abuse Regulation (EU) No 596/2014 (MAR) and Commission Delegated Regulation (EU) No...

Form 8.5 (EPT/RI) - Warpaint London Plc

FORM 8.5 (EPT/RI)PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)1. KEY INFORMATION(a) Name of exempt principal trader: Shore Capital Stockbrokers Ltd (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Warpaint London Plc ...

Form 8.5 (EPT/RI) - Brand Architekts Group plc

FORM 8.5 (EPT/RI)PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)1. KEY INFORMATION(a) Name of exempt principal trader: Shore Capital Stockbrokers Ltd (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Brand Architekts Group plc ...

Form 8.5 (EPT/RI) - NewRiver REIT Plc

FORM 8.5 (EPT/RI)PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)1. KEY INFORMATION(a) Name of exempt principal trader: Shore Capital Stockbrokers Ltd (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree NewRiver REIT Plc ...

Share buyback programme - week 49

Nasdaq Copenhagen Euronext Dublin London Stock Exchange Danish Financial Supervisory Authority Other stakeholders Date 9 December 2024 Share buyback programme - week 49 The share buyback programme runs in the period 1 February 2024 up to and including 27 January 2025, see company announcement of 31 January 2024. Part I of the programme, for DKK 750 million, was completed on 27 June 2024, see company announcement of 28 June 2024. Part II of the programme, for DKK 775 million and a...

MINING LEASE APPLICATION SUBMITTED FOR NORRA KÄRR

MINING LEASE APPLICATION SUBMITTED FOR NORRA KÄRRVancouver, December 8, 2024 – Leading Edge Materials Corp. (“ Leading Edge Materials ” or the “ Company ”) ( TSXV: LEM ) ( Nasdaq First North: LEMSE ) ( OTCQB: LEMIF ) announces that an application for an Exploitation Concession (“Bearbetningskoncession”) 25-year mining lease has been submitted to the Mining Inspectorate of Sweden (“Bergsstaten”) for the Norra Kärr Heavy Rare Earths (HREE) Project.Norra Kärr had previously been granted a...

Bionical Emas sells EMAS Pharma to Kester Capital following strategic review

Bionical Emas to further strengthen its position as a market leader in Early Access Programs and Clinical Trial Supply The Company will invest in global expansion and further specialised services to bring more life-changing medicines to patients around the worldTom Watson, CEO, and existing Executive Management Team, to remain in place at Bionical EmasRichard Lambie to join the Executive Leadership Team as Executive Vice President Clinical Trial SupplyLONDON, Dec.09, 2024...

Subsea7 share repurchases

Luxembourg – 9 December 2024 - Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced transactions made in accordance with its share repurchase programme during the week commencing 2 December 2024. Date on which the share repurchase programme was announced:25 July 2019, with a two-year extension announced on 19 April 2023. The duration of the share repurchase programme:until 18 April 2025. In the...

Shell plc Third Quarter 2024 Euro and GBP Equivalent Dividend Payments

SHELL PLC THIRD QUARTER 2024 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS December 9, 2024The Board of Shell plc today announced the pounds sterling and euro equivalent dividend payments in respect of the third quarter 2024 interim dividend, which was announced on October 31, 2024 at US$0.344 per ordinary share.Shareholders have been able to elect to receive their dividends in US dollars, euros or pounds sterling. Holders of ordinary shares who have validly submitted US dollars, euros or...

Kester Capital backs experienced management team in acquiring EMAS Pharma

EMAS Pharma strongly positioned as a leading independent CRO in fast-growing and global marketHighly experienced Board and Executive Team put in place with track record of value creation and operational excellence in the global CRO market Strong growth targeted through expansion of services, enhanced technology and broadened geographic reachContinued customer focus to provide highest quality operational excellence with bespoke and tailored clinical solutions The Company...

Vow ASA: Last day of the subscription period in the rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.Oslo, 9 December 2024: Reference...

Transaction in Own Shares

9 thDecember 2024 PayPoint plc ("PayPoint" or the "Company") Transaction in Own SharesThe Company announces today it has purchased the following number of its ordinary shares of £0.00333 each through Investec Bank plc (“Investec”). Ordinary Shares Date of purchase:6 thDecember 2024Aggregate number of ordinary shares purchased:11,997Lowest price per share (pence):815.00Highest price per share (pence):823.00Weighted average price per day (pence):...

Lleida.net's monthly turnover customers over 5,000 euros per month increase…

And, with respect to customers with billings of less than €500 per month, the company saw year-over-year growth of 13.6 percent.Lleida.net, which is listed in Madrid, Paris, New York, Stuttgart and Frankfurt, recorded cumulative sales of 13.95 million euros in the last three quarters of 2024, 12 percent more than last year.As of September 30, 2024, the company's cumulative EBITDA is €2.21 million, 1322% above the cumulative as of September 30, 2023.The company recently announced the...

Havila Shipping ASA: Financing update and invitation to fixed income investor…

Reference is made to the stock exchange notice on 1 October 2024 by Havila Shipping ASA (“ Havila Shipping ”) which provided information on lenders' decisions to either settle or extend their outstanding loans under the restructuring agreement. NOK 1,022 million of debt matures on 30 December 2024, whereof NOK 500 million shall be settled in cash and NOK 522 million shall be converted to shares. In order to refinance the 30 December 2024 maturities, Havila Finans AS a company wholly owned...

Arcadis completes share buyback program and reports final transactions

Arcadis completes share buyback program and reports final transactions Final transaction updateArcadis has repurchased 91,858 of its own shares in the period 2 December – 5 December 2024 at an average price of €63.21. The total consideration of this repurchase was € 5,806,498.Overviews of all transactions under this program are published in weekly press releases and on the website of Arcadis ( https://www.arcadis.com/en/global/investors/ ).ARCADIS INVESTOR RELATIONS Christine Disch |...

Jetex announced as the exclusive operator of Red Sea International Airport's…

Jetex to operate RSI's private aviation terminal following agreement with daa International The collaboration was formalized through an agreement between Jetex and daa International (daai), the operator of RSI, marking a new chapter in exceptional luxury aviation experience on Saudi Arabia's western coast.“With RSI, we were determined to create an airport that seamlessly blends beautiful design, exceptional experiences and a commitment to honoring nature. Soon, every passenger transiting...

Molecular Partners Presents Clinical Data Supporting its Ongoing MP0533 Study…

MP0533 phase 1/2a dose escalation study continues with overall acceptable safety profile to date as well as initial antileukemic and pharmacodynamic activityClinical protocol amendment in process with optimized dosing scheme to overcome target-mediated drug disposition and test the full potential of MP0533Switch-DARPin MP0621 demonstrates intended mechanism in vivo, achieving killing of cKit+ cells while reducing off-target effects seen with systemic anti-CD47 blockade ...

Admirals Group AS Announces a Sale of its Australian Subsidiary

Admirals Group AS has entered into an agreement to sell its wholly owned subsidiary, Admirals AU PTY Ltd (Australia), a licensed investment company, to a non-related party, as part of the Admirals group's ongoing optimization of its geographic focus. The transaction, subject to customary closing conditions, is expected to positively contribute to Admirals Group AS's net profit and streamline its operations in alignment with its core strategy. This strategic move underscores Admirals Group…

Merus' Petosemtamab Monotherapy Interim Data Continues to Demonstrate Clinically…

Petosemtamab in combination with pembrolizumab in 1L r/m PD-L1 expressing HNSCC ongoing with clinical data update planned for 2025Petosemtamab in mCRC evaluation expanded to include 1L and 3L+; initialclinical data planned for 2025– Conference Call on Saturday, December 7 that 9:00 a.m. ETUTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec.07, 2024(GLOBE NEWSWIRE) --Merus N.V.(Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company...

Brazilian Court Confirms Tenaris's Obligation to Pay Indemnification in…

/T Group under the Usiminas shareholders agreement), that had sought to revert the June 18, 2024 SCJ decision ordering the T/T Group to pay Companhia Siderúrgica Nacional, or CSN, an indemnification in connection with their 2012 acquisition of a participation in Usiminas.Notwithstanding the foregoing, the SCJ unanimously resolved to modify the applicable monetary adjustment mechanism and to cap the applicable attorney's fees, thereby lowering the aggregate amount that would be payable by the...

Extraordinary General Meeting announcement

SBM Offshore announces that the agenda of the Extraordinary General Meeting of Shareholders (EGM) and the invitation for shareholders to attend the EGM have now been published on the Company's website. The EGM will be held at the Sheraton Amsterdam Airport Hotel, Schiphol Boulevard 101, 1118 BG Amsterdam, the Netherlands on Friday January 17, 2025 at 3.30 p.m. Central European Time. Corporate Profile SBM Offshore is the world's deepwater ocean-infrastructure expert. Through...

Transaction in Own Shares

Transaction in Own Shares • • • • • • • • • • • • • • • • Shell plc (the 'Company') announces that on 06 December 2024 it purchased the following number of Shares for cancellation.Aggregated information on Shares purchased according to trading venue: Date of purchaseNumber of Shares purchasedHighest price paid Lowest price paidVolume weighted average price paid per shareVenueCurrency06/12/20241,326,000 £25.1150£24.6900£24.9072LSEGBP...

Initiation of Restructuring Processes for a part of Companies controlled by AUGA…

As announced on 11 November, 2024, AUGA group, AB (hereinafter - the Company) by the decision of the Board initiated the restructuring process of the Company, which was approved by the Extraordinary Meeting of Shareholders of the Company on 4 December, 2024. Additionally, the Board of the Company recommended to the managers of the group companies controlled by the Company to assess the need to initiate restructuring processes for individual companies of the Company's group.The group...

Altri Comunicati